Metraipolis › archive › dc_a03ef5908714

Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42201048
DOI
10.3390/medsci14020256
License (as archived)
solo-consultazione
Archived
2026-11-02T07:26:51.426Z
SHA-256 of the archived text
67e4ad860308d9d223e49227f7454566d19207a16b76eaf92366141d348ed3a4
Stable URL of this page
https://metraipolis.com/documento/dc_a03ef5908714

How to cite

Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048 — Europe PMC (en), https://europepmc.org/article/MED/42201048 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a03ef5908714 (Metraipolis archive dc_a03ef5908714, sha256 67e4ad860308d9d223e49227f7454566d19207a16b76eaf92366141d348ed3a4)
BibTeX
@misc{dca03ef5908714,
  title = {Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42201048},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a03ef5908714; sha256 67e4ad860308d9d223e49227f7454566d19207a16b76eaf92366141d348ed3a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201048. Agents can read the archived copy with the MCP tool read_document.